NEO NeoGenomics, Inc.
$15.94
NeoGenomics, Inc. (NEO) is expected to report earnings on October 27, 2026, after the market close. The consensus earnings estimate is a loss of $0.01 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +3.1% since its last earnings release on July 28, 2026.
NeoGenomics Beat Expectations, Raises Guidance
Tuesday, July 28, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 27
Tuesday · 4:05 PM ET
Earnings Whisper
-
vs ($0.01)
(GAAP)
Rev est $205.57M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$15.86
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About NeoGenomics, Inc.
NeoGenomics Inc operates a network of cancer-related testing laboratories in Ft. Myers and Tampa, Florida; Irvine, California; and Nashville, and Tennessee.
Sector
Healthcare
Industry
Medical Labs & Research